This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Martha H. Marsh, Retired President & CEO Of Stanford Hospital & Clinics, Named To The Owens & Minor Board Of Directors

Stocks in this article: OMI

Owens & Minor, Inc. (NYSE-OMI) announced today that its board of directors has elected Martha H. Marsh, retired President & Chief Executive Officer of Stanford Hospital & Clinics, to serve on the Owens & Minor board of directors, effective October 18, 2012. Marsh, 63, is expected to be nominated as a director for election by the shareholders at the April 2013 Annual Meeting of Owens & Minor’s Shareholders. Marsh retired from Stanford Hospital & Clinics in 2010, after leading the institution for eight years.

Prior to her leadership role at Stanford Hospital, which is affiliated with Stanford University, Marsh was Chief Executive Officer of the UC Davis Medical Center. She also served as Senior Vice President for Professional Services & Managed Care for the University of Pennsylvania Health System in Philadelphia, and prior to that, she served as the President & Chief Executive Officer of the Matthew Thornton Health Plan and as Chief Operating Officer of Elliott Hospital. Educated at the University of Rochester, Marsh earned MPH and MBA degrees from Columbia University. She currently serves on the board of AMN Healthcare Services, Inc.

“The wealth of expertise that Martha brings to Owens & Minor cannot be overstated,” said Craig R. Smith, president & chief executive officer of Owens & Minor. “She has been a leader in the healthcare industry and in hospital management for more than thirty years, and we will greatly benefit from her experience and knowledge of the acute-care industry.”

Marsh was named one of the nation’s 100 most powerful people in healthcare by Modern Healthcare magazine in 2004, and she has been named one of the Most Influential Women in Business by the San Jose Business Journal and the San Francisco Business Times over many years.

Owens & Minor, Inc. , (NYSE: OMI) a FORTUNE 500 company headquartered in Richmond, Virginia, is a leading national distributor of name-brand medical and surgical supplies and a healthcare supply-chain management company. Owens & Minor is also a member of the Russell 2000 ® Index, which measures the performance of the small-cap segment of the U.S. equity universe, as well as the S&P MidCap 400, which includes companies with a market capitalization of $1 billion to $4.4 billion that meet certain financial standards. With a diverse product and service offering and distribution centers throughout the United States, the company serves hospitals, integrated healthcare systems, alternate site locations, group purchasing organizations, healthcare suppliers, and the federal government. Owens & Minor provides technology and consulting programs that improve inventory management and streamline logistics across the entire medical supply chain--from origin of product to patient bedside. For news releases, or for more information about Owens & Minor, visit the company website at www.owens-minor.com.



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs